A detailed history of Integrity Advisory, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Integrity Advisory, LLC holds 17,109 shares of PACB stock, worth $30,796. This represents 0.13% of its overall portfolio holdings.

Number of Shares
17,109
Previous 33,086 48.29%
Holding current value
$30,796
Previous $192,000 27.6%
% of portfolio
0.13%
Previous 0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$5.67 - $11.2 $90,589 - $178,942
-15,977 Reduced 48.29%
17,109 $0
Q3 2022

Oct 17, 2022

BUY
$3.93 - $8.57 $73,978 - $161,321
18,824 Added 131.99%
33,086 $192,000
Q2 2022

Jul 27, 2022

BUY
$4.02 - $10.43 $12,023 - $31,196
2,991 Added 26.54%
14,262 $63,000
Q1 2022

May 05, 2022

BUY
$8.43 - $20.9 $95,014 - $235,563
11,271 New
11,271 $103,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $405M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Integrity Advisory, LLC Portfolio

Follow Integrity Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrity Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrity Advisory, LLC with notifications on news.